Tirzepatide and CCR both corrected metabolic abnormalities of obese mice, reducing body weight and fat mass ( Supplementary Figure 2A-C ) and normalized the levels of metabolic hormones and glucose in circulation ( Table S1 ), with more substantial metabolic effects elicited by CCR than by tirzepatide
Date: April 23, 2026 Source: Digestive Disease Week Summary: A new minimally invasive procedure may help people keep weight off after stopping popular drugs like Ozempic and semaglutidesomething most patients struggle with
These findings have important implications for the management of overweight and obesity, as well as the prevention of associated cardiometabolic risk factors
Bent AH, Parseghian C, Morris VK, Kee BK, Huey RW, Morelli MP, Shen JP, Jernigan K, Fernandez A, Harrison C, Horodecky K, Dasari A, Alfaro K, Aziz K, Kell RJ, Kopetz S